Bnp Paribas Asset Management Holding S.A. Bristol Myers Squibb CO Transaction History
Bnp Paribas Asset Management Holding S.A.
- $41 Billion
- Q2 2025
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 2,162,915 shares of BMY stock, worth $93.8 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
2,162,915
              Previous 2,144,340
              
        
           0.87%
        
      
          
        Holding current value
$93.8 Million
            Previous $131 Million
            
        
           23.44%
        
      
          
        % of portfolio
0.24%
            Previous 0.35%
          
        Shares
	  32 transactions
	
  Others Institutions Holding BMY
# of Institutions
2,668Shares Held
1.64BCall Options Held
22.4MPut Options Held
25.3M- 
    
      Vanguard Group Inc Valley Forge, PA195MShares$8.46 Billion0.15% of portfolio
- 
    
      Black Rock Inc. New York, NY159MShares$6.88 Billion0.15% of portfolio
- 
    
      Jpmorgan Chase & CO New York, NY108MShares$4.69 Billion0.52% of portfolio
- 
    
      State Street Corp Boston, MA94.7MShares$4.11 Billion0.17% of portfolio
- 
    
      Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.07 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $92.3B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...